2 results
Approved WMOWill not start
To determine the clinical efficacy and toxicity of ABT-869 in combination with paclitaxel in the first-line treatment of subjects with metastatic breast cancer.
Approved WMOCompleted
Objective of the study is to demonstrate that CRT parameter optimisation using SonR technology can improve the responder rate, when using LV remodeling as a reference, compared to Standard of Care.